Stockscreener 앱 받기
11.22
0.38%
0.03
전일 마감가:
$11.19
열려 있는:
$11.24
하루 거래량:
119.39K
Relative Volume:
0.11
시가총액:
$1.46B
수익:
$1.12B
순이익/손실:
$5.00M
주가수익비율:
1,122.00
EPS:
0.01
순현금흐름:
$-383.00M
1주 성능:
-2.15%
1개월 성능:
+18.99%
6개월 성능:
+10.67%
1년 성능:
-35.92%
1일 변동 폭
$11.16
$11.29
1주일 범위
$10.91
$11.49
52주 변동 폭
$7.33
$18.59
Indivior Plc Stock (INDV) Company Profile
명칭
Indivior Plc
전화
804-379-1090
주소
234 BATH ROAD, SLOUGH, BERKSHIRE
INDV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INDV
Indivior Plc
|
11.25 | 1.46B | 1.12B | 5.00M | -383.00M | 0.01 |
|
ZTS
Zoetis Inc
|
156.21 | 66.72B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.42 | 48.08B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.68 | 47.74B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.00 | 18.49B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.81 | 13.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Indivior Plc Stock (INDV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-28 | 개시 | Rodman & Renshaw | Buy |
| 2024-07-23 | 개시 | Piper Sandler | Overweight |
| 2024-04-03 | 개시 | Craig Hallum | Buy |
| 2023-07-13 | 개시 | Northland Capital | Outperform |
Indivior Plc 주식(INDV)의 최신 뉴스
Indivior to Participate in Upcoming Investor Events - StreetInsider
Indivior to Participate in Upcoming Investor Events | INDV Stock News - GuruFocus
Indivior announces participation in investor conferences By Investing.com - Investing.com India
Indivior to Engage with Investors at Key Healthcare Conferences - TipRanks
Drug Addiction Treatment Market Projected To Witness Massive - openPR.com
(INDV) Long Term Investment Analysis - news.stocktradersdaily.com
Drug Abuse Treatment Market Grows Amid Rising Substance Abuse - openPR.com
Indivior advances GABA-B PAM program for substance use disorders through IND-enabling studies - BioWorld MedTech
Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies - marketscreener.com
Shareholders of Indivior PLC Should Contact Levi & Korsinsky Before October 1, 2024 to Discuss Your RightsINDV - ACCESS Newswire
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Indivior PLC (INDV) - ACCESS Newswire
Indivior PLC Announces AGM Results with Key Resolutions Passed - TipRanks
Indivior PLC Sued for Securities Law ViolationsContact Levi & Korsinsky Before October 1, 2024 to Discuss Your Rights – INDV - ACCESS Newswire
Indivior PLC announces leadership and bylaw changes - Investing.com Australia
Indivior PLC announces leadership and bylaw changes By Investing.com - Investing.com Nigeria
Indivior PLC Announces Successful AGM Resolutions - TipRanks
Naloxone Market Set to Witness Significant Growth by 2025-2032 | - openPR.com
Investors who lost money on Indivior PLC (INDV) should contact Levi & Korsinsky about pending Class ActionINDV - ACCESS Newswire
Decoding Indivior PLC (INDV): A Strategic SWOT Insight - GuruFocus
Shareholders that lost money on Indivior PLC (INDV) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
When (INDV) Moves Investors should Listen - news.stocktradersdaily.com
New Study Highlights Monthly SUBLOCADE® as a Potential Treatment Option for Opioid Use Disorder During and After Pregnancy - The Malaysian Reserve
INDIVIOR PLC SEC 10-Q Report - TradingView
Indivior PLC Announces Total Voting Rights and Share Capital Update - TipRanks
Opioid Antagonist Market Is Booming Worldwide 2025-2032 | - openPR.com
Drug Detoxification Market Is Booming Worldwide 2025-2032 | - openPR.com
Evolving Landscape of Mental Health Segment: Key Market Insights of the Latest Published Substance Use Disorders Report — Alcohol Use Disorder, Cocaine Use Disorder, Opioid Use Disorder, and Cannabis Use Disorder | DelveInsight - GlobeNewswire Inc.
Indivior: Trying To Break Addiction (NASDAQ:INDV) - Seeking Alpha
Results: Indivior PLC Exceeded Expectations And The Consensus Has Updated Its Estimates - simplywall.st
Indivior PLC Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Yahoo Finance
Press Release Distribution & PR Platform - ACCESS Newswire
Indivior to release Q4 and full-year 2024 results on Feb 20 - MSN
Indivior Reports Q1 2025 Results, Maintains FY Guidance Amid Market Challenges - MSN
Indivior PLC (INDV) Trading 3.9% Higher on Apr 25 - GuruFocus
Indivior Announces Q1 2025 Financial Results - The Malaysian Reserve
Indivior Faces Revenue Challenges Amid Competitive Pressures - TipRanks
Indivior Q1 2025 Earnings Call Transcript - MarketBeat
Indivior (INDV) Q1 2025 Earnings Call - Mitrade
FTSE 250 movers: Indivior surges; Inchcape slips - Sharecast.com
Indivior PLC (INDV) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
Indivior PLC Q1 2025 Earnings: EPS of $0.38 Beats Estimate, Revenue Hits $266 Million - GuruFocus
Indivior Q1 2025 Financial Results - TradingView
Indivior (INDV) Surpasses Q1 Revenue Projections with $266M Repo - GuruFocus
Indivior shares surge following robust Q1 revenue and positive outlook By Investing.com - Investing.com Nigeria
Indivior Plc (INDV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.16%
3.29%
자본화:
|
볼륨(24시간):